Medicinal products for human use: monthly figures - September 2024

Training webinar on Product Management Service (PMS) Product User Interface (PUI), Online, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 11:00 (CEST)

Human medicines European public assessment report (EPAR): Ciambra, pemetrexed, Date of authorisation: 02/12/2015, Revision: 7, Status: Withdrawn (authorisation)

Babesia (B. microti, B, duncani, B. divergens, and B. venatorum) DNA and RNA - Notified body 2797 - 19/11/2021 - View in the context of the performance evaluation consultation procedure (PECP)

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 18, Status: Authorised

Shoulder prostheses - Notified body 0459 - 25/08/2022 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Medical device expert panels

Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions

Class D in vitro diagnostic devices: expert panel views

Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 27, Status: Authorised